Filing Details

Accession Number:
0000914190-19-000261
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-09 16:12:05
Reporting Period:
2019-08-07
Accepted Time:
2019-08-09 16:12:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
842023 Bio-Techne Corp TECH Biological Products, (No Disgnostic Substances) (2836) 411427402
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1258704 V Robert Baumgartner 5775 Wayzata Boulevard, Suite 400
Minneapolis MN 55416
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-07 500 $191.06 8,726 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (Right to Buy) $70.35 2011-10-27 2021-10-26 5,000 5,000 Direct
Common Stock Stock Options (Right to Buy) $66.90 2012-10-25 2022-10-24 5,000 5,000 Direct
Common Stock Stock Options (Right to Buy) $87.39 2013-10-31 2023-10-30 4,000 4,000 Direct
Common Stock Stock Options (Right to Buy) $91.78 2014-10-30 2024-10-30 4,000 4,000 Direct
Common Stock Stock Options (Right to Buy) $87.34 2016-10-29 2025-10-28 4,260 4,260 Direct
Common Stock Stock Options (Right to Buy) $101.19 2017-10-26 2026-10-26 3,985 3,985 Direct
Common Stock Stock Options (Right to Buy) $125.05 2018-10-25 2027-10-26 3,125 3,125 Direct
Common Stock Stock Options (Right to Buy) $179.84 2028-10-25 1,898 1,898 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-10-26 5,000 5,000 Direct
2022-10-24 5,000 5,000 Direct
2023-10-30 4,000 4,000 Direct
2024-10-30 4,000 4,000 Direct
2025-10-28 4,260 4,260 Direct
2026-10-26 3,985 3,985 Direct
2027-10-26 3,125 3,125 Direct
2028-10-25 1,898 1,898 Direct
Footnotes
  1. This option vests on the earlier of the one year anniversary of the grant date (10/25/2019) or the date of Bio-Techne 2019 Annual Meeting of Shareholders.